Fibrotic progression from acute cellular rejection is dependent on secondary lymphoid organs in a mouse model of chronic lung allograft dysfunction

Mineura, Katsutaka; Tanaka, Satona; Goda, Yasufumi; Terada, Yuriko; Yoshizawa, Akihiko; Umemura, Keisuke; Sato, Atsuyasu; Yamada, Yoshito; Yutaka, Yojiro; Ohsumi, Akihiro; Nakajima, Daisuke; Hamaji, Masatsugu; Mennju, Toshi; Kreisel, Daniel; Date, Hiroshi

doi:10.1016/j.ajt.2024.02.020

American Journal of Transplantation

2024

DOI: 10.1016/j.ajt.2024.02.020

|View full text |Cite

Fibrotic progression from acute cellular rejection is dependent on secondary lymphoid organs in a mouse model of chronic lung allograft dysfunction

Katsutaka Mineura,

Satona Tanaka,

Yasufumi Goda

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 48 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Chronic Lung Allograft Dysfunction: Clinical Manifestations and Immunologic Mechanisms

Bery,

Belousova,

Hachem

et al. 2024

Transplantation

View full text Add to dashboard Cite

The term “chronic lung allograft dysfunction” has emerged to describe the clinical syndrome of progressive, largely irreversible dysfunction of pulmonary allografts. This umbrella term comprises 2 major clinical phenotypes: bronchiolitis obliterans syndrome and restrictive allograft syndrome. Here, we discuss the clinical manifestations, diagnostic challenges, and potential therapeutic avenues to address this major barrier to improved long-term outcomes. In addition, we review the immunologic mechanisms thought to propagate each phenotype of chronic lung allograft dysfunction, discuss the various models used to study this process, describe potential therapeutic targets, and identify key unknowns that must be evaluated by future research strategies.

show abstract

Chronic Lung Allograft Dysfunction: Clinical Manifestations and Immunologic Mechanisms

Bery,

Belousova,

Hachem

et al. 2024

Transplantation

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Fibrotic progression from acute cellular rejection is dependent on secondary lymphoid organs in a mouse model of chronic lung allograft dysfunction

Cited by 1 publication

References 48 publications

Chronic Lung Allograft Dysfunction: Clinical Manifestations and Immunologic Mechanisms

Chronic Lung Allograft Dysfunction: Clinical Manifestations and Immunologic Mechanisms

Contact Info

Product

Resources

About